• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病的治疗:从标准药物疗法到纳米技术疗法。

Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy.

作者信息

Zhu Baohua, Jing Mingyi, Yu Qianying, Ge Xiaopei, Yuan Fan, Shi Lanhui

机构信息

Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Surgery of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Postepy Dermatol Alergol. 2022 Jun;39(3):460-471. doi: 10.5114/ada.2021.108445. Epub 2021 Aug 16.

DOI:10.5114/ada.2021.108445
PMID:35950130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9326914/
Abstract

Psoriasis is a genetic chronic disease mediated by the immune system with systemic and cutaneous manifestations that can significantly deteriorate patients' quality of life. Two-three percent of the population worldwide suffer from psoriasis and it imposes a substantial economic burden on patients. The aetiology is mainly related with genes and environmental factors. The pathophysiology of psoriasis is characterized by T cells and dendritic cells, antimicrobial peptides, genetic predispositions, lipoprotein-2, galactosin-3, fractalkine, vaspin, and human neutrophilic peptides, etc. in the progression of psoriasis. For patients with psoriasis, the traditional treatments include corticosteroids, vitamin D analogues, calcineurin inhibitors, methotrexate, cyclosporine, acitretin, phototherapy, and biological agents, etc. Nanodermatology is an emerging, multidisciplinary science that is gaining increasing recognition in the treatment of psoriasis. This review provides a summary of the pathophysiology, epidemiology, clinical diagnosis, and classical pharmacotherapy of psoriasis. The review also summarizes different nanotechnology therapies for effective treatment of psoriasis.

摘要

银屑病是一种由免疫系统介导的遗传性慢性疾病,具有全身和皮肤表现,可显著降低患者的生活质量。全球2%-3%的人口患有银屑病,给患者带来了沉重的经济负担。其病因主要与基因和环境因素有关。银屑病的病理生理学特征在于T细胞和树突状细胞、抗菌肽、遗传易感性、脂蛋白-2、半乳凝素-3、趋化因子、内脏脂肪素和人嗜中性粒细胞肽等在银屑病进展过程中的作用。对于银屑病患者,传统治疗方法包括皮质类固醇、维生素D类似物、钙调神经磷酸酶抑制剂、甲氨蝶呤、环孢素、阿维A、光疗和生物制剂等。纳米皮肤病学是一门新兴的多学科科学,在银屑病治疗中越来越受到认可。本文综述了银屑病的病理生理学、流行病学、临床诊断和经典药物治疗方法。同时,本文还总结了不同的纳米技术疗法在有效治疗银屑病方面的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f6/9326914/9b745962a8d7/PDIA-39-44931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f6/9326914/56ed23517656/PDIA-39-44931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f6/9326914/5628a69e0c76/PDIA-39-44931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f6/9326914/9b745962a8d7/PDIA-39-44931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f6/9326914/56ed23517656/PDIA-39-44931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f6/9326914/5628a69e0c76/PDIA-39-44931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f6/9326914/9b745962a8d7/PDIA-39-44931-g003.jpg

相似文献

1
Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy.银屑病的治疗:从标准药物疗法到纳米技术疗法。
Postepy Dermatol Alergol. 2022 Jun;39(3):460-471. doi: 10.5114/ada.2021.108445. Epub 2021 Aug 16.
2
Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.中重度斑块状银屑病的紫外线光疗管理:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(27):1-66. Epub 2009 Nov 1.
3
Psoriasis: a brief overview.银屑病:简要概述。
Clin Med (Lond). 2021 May;21(3):170-173. doi: 10.7861/clinmed.2021-0257.
4
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review.银屑病的病理生理学、临床表现和治疗:综述。
JAMA. 2020 May 19;323(19):1945-1960. doi: 10.1001/jama.2020.4006.
5
Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study.中重度银屑病传统治疗方法的有效性和成本的回顾性分析:一项意大利单中心研究。
J Dermatolog Treat. 2016 Oct;27(5):399-405. doi: 10.3109/09546634.2015.1133885. Epub 2016 Jan 28.
6
Psoriasis.银屑病
J R Coll Physicians Edinb. 2013;43(4):334-8; quiz 339. doi: 10.4997/JRCPE.2013.414.
7
Nanodermatology-based solutions for psoriasis: State-of-the art and future prospects.基于纳米皮肤科学的银屑病解决方案:现状与未来展望。
Dermatol Ther. 2019 Nov;32(6):e13113. doi: 10.1111/dth.13113. Epub 2019 Oct 21.
8
Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment.头皮银屑病的管理:联合治疗中使用皮质类固醇的指南
Drugs. 2001;61(11):1593-8. doi: 10.2165/00003495-200161110-00006.
9
Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis.针对急性点滴状银屑病或慢性银屑病急性点滴状发作的非抗链球菌干预措施。
Cochrane Database Syst Rev. 2019 Apr 8;4(4):CD011541. doi: 10.1002/14651858.CD011541.pub2.
10
Therapy of moderate and severe psoriasis.中重度银屑病的治疗。
GMS Health Technol Assess. 2006 Apr 26;2:Doc07.

引用本文的文献

1
Recent advancement of fisetin-based nanoformulations in the management of psoriasis.基于漆黄素的纳米制剂在银屑病治疗中的最新进展。
Discov Nano. 2025 Jul 7;20(1):105. doi: 10.1186/s11671-025-04298-4.
2
Therapeutic Potential of Curcumin and Novel Formulations in Psoriasis Treatment: Evidence and Future Prospects.姜黄素及其新型制剂在银屑病治疗中的治疗潜力:证据与未来展望
Drug Des Devel Ther. 2025 Jun 25;19:5387-5414. doi: 10.2147/DDDT.S520555. eCollection 2025.
3
Tapinarof Nanogels as a Promising Therapeutic Approach.他扎罗汀纳米凝胶作为一种有前景的治疗方法。

本文引用的文献

1
Transfersomes: A Promising Nanoencapsulation Technique for Transdermal Drug Delivery.传递体:一种用于透皮给药的有前景的纳米包封技术。
Pharmaceutics. 2020 Sep 9;12(9):855. doi: 10.3390/pharmaceutics12090855.
2
Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition.用于增强皮肤滞留局部递送的载姜黄素纳米结构脂质载体:优化、放大、体外表征及离体皮肤沉积评估
Eur J Pharm Sci. 2020 Sep 1;152:105438. doi: 10.1016/j.ejps.2020.105438. Epub 2020 Jun 27.
3
Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.
Pharmaceutics. 2025 Jun 1;17(6):731. doi: 10.3390/pharmaceutics17060731.
4
Sinhyotaklisan as a Potential Therapeutic for Psoriasis: Network Pharmacology and Experimental Validation.辛荷他克立散作为银屑病的一种潜在治疗药物:网络药理学与实验验证
Int J Mol Sci. 2025 May 25;26(11):5082. doi: 10.3390/ijms26115082.
5
Hypoxia-induced RHCG as a key regulator in psoriasis and its modulation by secukinumab.缺氧诱导的RHCG作为银屑病的关键调节因子及其被司库奇尤单抗的调节作用
APL Bioeng. 2025 May 9;9(2):026115. doi: 10.1063/5.0250742. eCollection 2025 Jun.
6
Development and Evaluation of Hydrogel-Based Sulfasalazine-Loaded Nanosponges for Enhanced Topical Psoriasis Therapy.用于增强局部银屑病治疗的水凝胶基载柳氮磺胺吡啶纳米海绵的研制与评价
Pharmaceuticals (Basel). 2025 Mar 10;18(3):391. doi: 10.3390/ph18030391.
7
Combination Effects of Aminolevulinic Acid and Mycophenolic Acid on Hacat Cell Proliferation and Inhibition of Inosine Monophosphate Dehydrogenase.氨基乙酰丙酸和霉酚酸对HaCaT细胞增殖及肌苷单磷酸脱氢酶抑制的联合作用
Molecules. 2025 Mar 18;30(6):1359. doi: 10.3390/molecules30061359.
8
Comparative study between botulinum toxin and topical steroid in treatment of psoriasis vulgaris.肉毒杆菌毒素与外用类固醇治疗寻常型银屑病的对比研究。
Arch Dermatol Res. 2025 Mar 8;317(1):537. doi: 10.1007/s00403-025-03986-6.
9
Plant-Based Foods for Chronic Skin Diseases: A Focus on the Mediterranean Diet.用于慢性皮肤病的植物性食物:聚焦地中海饮食。
Curr Nutr Rep. 2025 Mar 6;14(1):42. doi: 10.1007/s13668-025-00632-5.
10
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).布罗达单抗治疗中度至重度银屑病的有效性:一项回顾性、真实世界多中心研究,重点关注肥胖和多次治疗失败患者-IL PSO(意大利银屑病概况)
J Clin Med. 2025 Feb 8;14(4):1087. doi: 10.3390/jcm14041087.
目前针对银屑病的治疗方法及未来展望——聚焦于血清素能药物。
Mol Neurobiol. 2020 May;57(5):2391-2419. doi: 10.1007/s12035-020-01889-3. Epub 2020 Feb 15.
4
Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity.将水不溶性雷公藤红素载入类脂体水凝胶中以提高局部渗透和抗银屑病活性。
Colloids Surf B Biointerfaces. 2019 Oct 1;182:110352. doi: 10.1016/j.colsurfb.2019.110352. Epub 2019 Jul 8.
5
Preparation, characterization, and evaluation of cyclosporine cationic liposomes for the treatment of psoriasis.环孢菌素阳离子脂质体的制备、表征及治疗银屑病的评价。
J Liposome Res. 2020 Mar;30(1):68-79. doi: 10.1080/08982104.2019.1593449. Epub 2019 Apr 23.
6
Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats.载阿普司特聚乳酸-羟基乙酸共聚物纳米粒的制备及其在大鼠体内的药代动力学研究。
Int J Nanomedicine. 2019 Mar 1;14:1587-1595. doi: 10.2147/IJN.S195048. eCollection 2019.
7
Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.载二羟蒽酮的纳米结构脂质载体凝胶改善咪喹莫特诱导的小鼠银屑病斑块模型中的银屑病。
Drug Dev Ind Pharm. 2019 May;45(5):826-838. doi: 10.1080/03639045.2019.1576722. Epub 2019 Feb 14.
8
Understanding the prospective of nano-formulations towards the treatment of psoriasis.了解纳米制剂在治疗银屑病方面的前景。
Biomed Pharmacother. 2018 Nov;107:447-463. doi: 10.1016/j.biopha.2018.07.156. Epub 2018 Aug 10.
9
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.固定剂量卤倍他索-他扎罗汀复方制剂治疗中重度斑块状银屑病的安全性和疗效:两项 3 期随机对照研究结果。
J Am Acad Dermatol. 2018 Aug;79(2):287-293. doi: 10.1016/j.jaad.2018.03.040. Epub 2018 Apr 1.
10
Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo-in vivo evaluation study.阿维A纳米囊泡凝胶在银屑病有效治疗中的关键作用:体内外评价研究
Int J Nanomedicine. 2018 Feb 20;13:1059-1079. doi: 10.2147/IJN.S156412. eCollection 2018.